Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Wu, H., Lin, L., Giblin, F., Ho, Y
Peptide safety during perimenopause Generally safe peptides: CJC-1295 + Ipamorelin (excellent safety record) BPC-157 (very safe long-term) Selank (minimal side effects) Semax (well-tolerated) GHK-Cu (safe topical and injectable) Start conservatively: Lower doses than younger women Hormones already unstable More sensitive during transition Titrate slowly Monitor carefully: Track symptoms meticulously Regular bloodwork Adjust based on response Stop if concerning effects Contraindications and cautions Avoid peptides if: Active cancer (theoretical GH concerns) Uncontrolled hypertension Severe kidney or liver disease Use caution with: Breast cancer history (discuss with oncologist) Diabetes (monitor glucose with GLP-1s) Thyroid issues (monitor thyroid function) Multiple medications (check interactions) Discuss with physician: Any chronic health conditions If on multiple medications Cancer history Cardiovascular issues See our peptide safety and risks , are peptides legal , research vs pharmaceutical peptides , and peptides vs SARMS
GHRP-6 + GHRH Analogs (General) The same synergistic principle applies to any GHRH analog, including tesamorelin and sermorelin
Mary James, ND Hot flashes and night sweats are episodes of sudden and profuse heat sensations that spread quickly through the upper part of the body
The trial reported no adverse events
10.1016/j.riam.2009.06.003 69 LeeJ
